نتائج البحث 461-470 من 7337 لعملية البحث عن preventionintroduction
... preventing long-term disability. The infectious risks and other complications associated with higher-efficacy treatments highlight the need to quantify ...
... prevention strategies. Phase 2 Trial of Voyager V1 in Combination With Cemiplimab in Cancer Patients. Rochester, Minn., Jacksonville, Fla., Scottsdale ...
However, the use of anti-inflammatory agents in the prevention of colorectal cancer is controversial, although there is some suggestion that its use may lower ...
Imad Absah, M.D.. Rochester, MN. Michael J. Ackerman, M.D., Ph.D.
In addition to exploring ED treatment patterns and success of both ischemic and bleeding risk stratification prior to definition ... prevention setting for the ...
The purpose of this study is to determine the safety, effcicacy and tolerability of H2NVAC in patients with HER2-expressing DCIS in order to prevent future ...
... prevent further dose increases (i.e., the MTD or recommended phase 2 dose), and the dose-limiting toxicity (DLT). The secondary objectives are to evaluate ...
... preventing tumor growth in paitents with recurrent recurrent and/or metastatic pancreatic cancer (met-PC). Combination Therapy of Acalabrutinib, Venetoclax ...
لا تُقدم Mayo Clinic الدعم للشركات أو المنتجات المُعلَّن عنها هنا. لكن تدعم العائدات الإعلانية رسالتنا غير الربحية.
تحقق من هذه الكتب الأكثر مبيعًا والعروض الخاصة على الكتب والنشرات الإخبارية من Mayo Clinic Press.
تساهم التبرّعات، وهي قابلة للخصم الضريبي، في دعم آخر التطورات في الأبحاث وطرق الرعاية لإحداث نقلة نوعية في الطب.